L-A is a persistent double-stranded RNA virus commonly found in the yeast Saccharomyces cerevisiae. Isolated L-A virus synthesizes positive strand transcripts in vitro. We found that the 5' termini of the transcripts are diphosphorylated.
The 5' cap (m 7 GpppXp) and 3' poly(A) tail structures are the hallmark of eukaryotic mRNAs and have important biological functions in promoting stability in the nucleus, transport to the cytoplasm, and translation and stability in the cytoplasm. Therefore, many viruses furnish their transcripts with the 5' cap structure utilizing their own or cellular enzymes, or even by snatching the structure from cellular mRNAs (1 -3) . Transcripts made by T7 RNA polymerase are recognized as foreign and induce innate immune responses in animal cells. Recent studies suggest that the 5' triphosphate of the transcripts as well as secondary structure, are involved in these responses (4, 5) . Therefore, the 5' end of RNA bears important information concerning on self or non-self for the host cells.
L-A is a persistent double-stranded RNA (dsRNA) 1 virus commonly found in the laboratory strains of the yeast Saccharomyces cerevisiae (6) . The virus has no extracellular transmission pathway. The viral genome is 4.6 kb long and only one strand (the positive strand) encodes proteins: The major 76 KDa coat protein Gag and a minor 170 KDa Gag-Pol (7, 8) . The minor protein is made from the two overlapping genes by a -1 ribosomal frameshifting mechanism (9) . The Pol domain of the fusion protein has the consensus motifs for RNA-dependent RNA polymerases. The RNA genome is packed inside of a 39 nm icosahedral shell consisting of 60 Gag heterodimers (10, 11) . One molecule or two of Gag is replaced by Gag-Pol because the fusion protein is essential for RNA encapsidation and replication. L-A virions have transcriptase activity to synthesize full-length positive strands from the dsRNA genome in a conservative way (12) . The transcripts are extruded from the virions and serve as templates for translation and also as substrates for encapsidation to form new virions. Once encapsidated, the positive strand is converted to dsRNA by the replicase activity associated with the virion.
M1, a satellite RNA of L-A virus, requires L-A encoded proteins to encapsidate and replicate its RNA genome. M1 dsRNA (1.6 to 1.8 kb) encodes a secreted protein toxin (killer toxin) that kills M1-free, toxin-sensitive strains (13) . Using this killer phenotype as a marker various host chromosomal genes have been identified which affect replication and maintenance of M1 and L-A. Mutations in SKI genes (SKI1, 2, 3, 4, 6, 7, and 8) cause an elevated copy number of L-A and, in the presence of M1, exhibit a "superkiller" phenotype (14, 15) .
Degradation of mRNA in eukaryotes usually begins with shortening of the poly(A) tail at the 3' end followed by decapping at the 5' end by the Dcp1p-Dcp2p decapping enzyme. Decapping generates the mRNA body with 5' monophosphate, which is then degraded by the SKI1/XRN1 5' exonuclease (16, 17) . Alternatively, the deadenylated RNA is digested by a multiprotein complex with 3' exonuclease activity called the exosome. Products of SKI2, 3, 4, 6, 7 , and 8 are auxiliary or core components of the cytoplasmic exosome (18, 19) . These gene products are also known to prevent translation from RNA without 3' poly(A) tail (20, 21) .
Previously we observed a strong antiviral activity of SKI1 against L-A virus (22) . Deletion of SKI1 elevated the copy number of L-A 5-to 10-fold and overexpression of the gene cured L-A virus from cells at a high frequency. In the replication cycle of L-A virus only positive strand transcripts are released from virions into the cytoplasm. We therefore reasoned that the L-A transcript at this stage is vulnerable to the SKI1 5' exonuclease.
The nuclease requires 5' monophosphorylated RNA as substrate, while the 5' end of L-A transcript has not been well established. It was reported about three decades ago that the 5' terminus was triphosphorylated (23) or diphosphorylated (24) . Here we establish that L-A has diphosphate at the 5' end. More significantly we demonstrate that the phosphate group of GTP or GMP, when the nucleotide was incorporated at the 5' end of the transcript, was converted to diphosphate. The virus, thus, clearly avoids 5' trior monophosphorylated transcripts. Our work may shed light on the metabolism of non-self RNA in yeast, especially on the role of phosphate groups at the RNA 5' end. (25) . L-A proteins expressed from plasmid pAB2 support replication of M1 in this strain. Cells were grown in rich YPAD medium (1% yeast extract, 2% peptone, 0.04% adenine sulphate, and 2% glucose) or synthetic medium deprived of uracil (H-ura) or trp (H-trp) (26). L-A and M1 virions were isolated and purified through CsCl gradient centrifugation as described in (27) .
EXPERIMENTAL PROCEDURES

Strains and Media
Transcription Reaction-The standard transcription reaction mixture contained 50 mM Tris HCl pH 7.5, 5 mM MgCl 2 , 0.1 mM EDTA, 20 mM NaCl, 5 mM KCl, 1 mM DTT, 2.5 mg of bentonite per ml, 0.5 mM each ATP, CTP, GTP and UTP. When a radioactive nucleotide was used, the concentration was reduced to 20 µM. The reaction was started by the addition of purified L-A or M1 virions and incubated at 30 ºC. The RNA products were extracted with phenol, phenolchloroform and precipitated with ethanol. Then the RNA was separated in either a 1.3% agarose or a 15% acryalamide gel, depending on the size of the products. Radioactive products were visualized by autoradiography. Non-radioactive RNA was detected by ethidium bromide staining or by Northern hybridization (28) using a 32 P-labeled specific probe.
Ski1p-TAP Purification-Tandem affinity purification (TAP)-tagged Ski1p was expressed in strain 2928-4 (a ura3 trp1 his3, L-A-o, L-BC) harboring plasmid pRE1004 by growing the cells in H-ura medium in which glucose was substituted with 2% galactose. pRE1004 is a derivative of pEMBLyex4 (29) with a 5.3 kb BamHI fragment that contains the entire SKI1 coding sequence directly fused to TAP at the carboxyl terminus. The expression of the protein is under the control of the GAL1-CYC hybrid promoter. Ski1p-TAP was purified in a single-step purification with calmodulin affinity resin (Stratagene) (30, 31 Fig. 6A ) contained the highest concentration of Ski1p-TAP (0.09 mg/ml) among elutes, estimated by Bradford method (32) using BSA as standard.
T7 Transcripts with Different 5' Ends-T7
transcripts with different 5' ends were made by run-off transcription with T7 RNA polymerase as described in (33) . 5' monophosphorylated and capped RNAs were synthesized by the addition of an excess amount of GMP and m 7 GpppG cap analogue, respectively, over GTP. We used PvuIIdigested pTF60 as template. pTF60 contains only two extra Gs between the T7 promoter and the entire X cDNA sequence (27) . X (530 bp) is a mutant of L-A with a large internal deletion (34 
RESULTS
L-A Transcript has Diphosphate at the 5'
End-Purified L-A virions have RNA polymerase activity and synthesize full-length positive-strand transcripts using the dsRNA genome as template. The RNA products were resistant to Terminator 5' exonuclease (Fig. 1A, lane 2) . The enzyme processively hydrolyzes single-stranded RNA with 5' monophosphate in a 5'-3' direction. Pretreatment with RNA 5' polyphosphatase, however, converted the RNA to full sensitivity to the 5' exonuclease (Fig. 1A, lane 4) . The polyphosphatase removes the γ and β phosphates from 5' tri-or diphosphorylated RNA but has no activity on RNA with a 5' cap. These results indicate that the L-A transcripts have no 5' cap structure and suggest that the transcripts are tri-or diphosphorylated at their 5´ends.
The 5' region of L-A positive strand starts with a G followed by an AU-rich sequence (Fig.  1B, upper diagram) . The first U and C appear at positions 7 and 17, respectively. When L-A virions were incubated only with GTP and ATP, a short transcript (6 nt) was produced (Fig. 1B, lane  2) . A further inclusion of UTP in the reaction increased the length to 16 nt (Fig. 1B, lane 3) . These short transcripts were apparently released from the RNA polymerase complex because of the lack of incoming nucleotides for elongation. The addition of CTP at 30 min did not convert the 16 nt species into full-size transcript (Fig. 1B, lane 9) , and we did not observe these short transcripts when virions were incubated with four NTPs (Fig.  1B, lane 10) . The 16 nt transcript has a single G at the 5' end, therefore only the 5' terminal nucleotide in the molecule can be labeled with [α-32 P]GTP. This transcript was purified from an acrylamide gel and treated with 5' exonuclease. As shown in Fig. 1C this species was resistant to the 5' exonuclease but became sensitive to it after treatment with RNA 5' polyphosphatase, a characteristic similar to the one observed with the full-size transcript. Then the 16 nt transcript labeled with [α-32 P]GTP was digested with S1 nuclease and analyzed on PEI cellulose. S1 degrades single-stranded RNA endonucleolytically to yield 5'-phosphoryl-terminated products. As shown in Fig. 1D (left panel), the labeled 5' terminal nucleotide comigrated with GDP, indicating that the L-A transcript has a diphosphate at the 5' end. Among the guanine nucleotides examined, GDP was the best substrate for the initiation reaction, consistent with the results that the 5' end of the transcript is diphosphorylated. GMP was also incorporated well into the 16 nt transcript ( Fig. 2A , lane 4). A cap analogue (m 7 GpppG) could initiate transcription whose product run as a 17mer because of the extra m 7 G at the 5' end ( Fig. 2A,  lane 7 ). This 17mer, unlike GTP-or GDP-primed transcript, was resistant to the 5' exonuclease even after treatment with RNA 5' polyphosphatase (Fig.  2B , lane 6). The 17mer was converted to 5' monophosphorylated 16mer by the tobacco acid pyrophosphatase (Fig. 2B, lane 7) , and the resulting product was now sensitive to the 5' exonuclease (Fig. 2B, lane 8) . These results clearly demonstrate that a cap analogue (m 7 GpppG) can be incorporated into the 5' end of the transcript, and that GDP is not essential for transcription initiation. GTP and GDP analogues (γ-S-GTP and β-S-GDP) could initiate transcription and the amounts of 16 nt transcripts were comparable to those produced by the respective bona fide nucleotides (Fig. 2C) . Because γ-S-GTP is nonhydrolysable, the results again confirm that GDP is not essential for initiation. It also indicates that transcription initiation and conversion of the 5' triphosphate of the transcript (or GTP) to 5' diphosphate are two distinct reactions.
GDP is not Essential for Transcription
GMP-Primed Transcript Has
Diphosphate at the 5' End-GMP can initiate transcription as efficiently as GDP. The 16 nt product was resistant to Terminator 5' exonuclease ( Fig. 2A, lane 1) , indicating that its 5' end is no longer monophosphorylated. We speculated that the 5' end of the molecule was modified to diphosphate. To prove this, we carried out the transcription reaction in the presence of [γ-32 P]ATP. As shown in Fig. 3A , the 16 nt transcript incorporated radioactivity only when transcription was primed with GMP. The labeled transcript was then isolated from the gel and digested with S1 nuclease. The radioactivity comigrated with GDP in PEI cellulose (Fig. 3B, lane 2) , indicating that the GMP-primed transcript has diphosphate at the 5' end. Furthermore, the transcript released labeled inorganic phosphate when treated with bacterial alkaline phosphatase (Fig. 3B, lane 4) or RNA 5' polyphosphatase (Fig. 3B, lane 3) . Because the latter enzyme cannot act on 5' monophosphorylated RNA, this result clearly demonstrated that the labeled phosphate derived from [γ-32 P]ATP was present in the β-position of the 5' diphosphate in the transcript. Furthermore, since the GDP-primed transcript was not labeled, this result indicates that the labeled β phosphate was acquired by a kinase reaction but not by a simple exchange reaction.
Nucleoside
Triphosphatase Activity Associated with L-A Virions-The 5' triphosphate of GTP was converted to diphosphate when the nucleotide was incorporated into the 5' end of L-A transcript. It suggests that the L-A virion has RNA or nucleoside triphosphatase activity. It is known that the yeast CTL1 gene product possesses RNA triphosphatase activity (35) . It localizes in the cytoplasm but its physiological role is unknown. A ctl1Δ strain is viable and can harbor L-A virus. L-A virions isolated from this mutant had transcriptase activity and synthesized the 16 nt transcript in the absence of CTP (not shown). The 16 nt transcript labeled with [α-32 P]GTP was gelpurified and treated with S1 nuclease. As shown in Fig. 1D (right panel) , the 5' terminal nucleotide released by S1 digestion was GDP, indicating that the transcript had a diphosphate at its 5' terminus. Therefore, CTL1 is not responsible for the conversion of triphosphate to diphosphate.
We found a weak nucleoside triphosphatase activity associated with L-A virions in a CsCl gradient (Fig. 4D) . A gradient from an L-A-negative strain had no such activity (Fig. 4C) . The L-A peak fraction (Fr. 5) released a low amount of Pi from ATP or GTP alone, but its activity was greatly stimulated when both nucleotides were present together (Supplemental Fig. 1SA ). GTP can be replaced by GDP, γ-S-GTP, or β-S-GDP for stimulation, all of which can prime the transcription reaction, while a non-priming nucleotide CTP failed to stimulate Pi release (Supplemental Fig. 1SA and B) . A potent inorganic pyrophosphatase activity has been observed to be associated with L-A virions (36) . It is likely that the enhanced release of Pi was not caused by nucleoside triphosphatase activity per se but by hydrolysis of inorganic pyrophosphate generated as a byproduct from polymerization of the 6 nt transcript (5' GAAAAA). Therefore, we carried out the reaction using [α-32 P]GTP and directly analyzed the products with PEI cellulose. As shown in Fig. 4E , lane 2, the L-A peak fraction (Fr. 5) produced GDP, confirming its triphosphatase activity. In the presence of ATP, the label in GDP decreased and a new radioactive spot migrating between GDP and GTP appeared (Fig.  4E, lane 4) . We confirmed that the latter spot comigrated with the gel-purified 6 nt 5' GAAAAA transcript. Because this transcript has a single G in the molecule, the results raise the possibility that GDP produced by the nucleoside triphosphatase activity was incorporated into its 5' end, resulting in the concomitant loss of radioactivity in GDP. When a similar reaction was carried out by substituting ATP with CTP, however, the label in GDP again decreased by the addition of CTP (Fig.  4F, lane 4) . Because CTP cannot support polymerization of even short transcripts without ATP and UTP, the results suggest that the decrease of GDP was not caused by its incorporation into RNA transcripts but by the competitive inhibition of the triphosphatase activity by ATP or CTP. It is also possible that unincorporated GDP was reconverted to GTP by virion-associated nucleoside diphosphate kinase (36) .
M1 Transcript has Diphosphate at the 5'
End-M1, a satellite RNA of L-A virus, utilizes L-A encoded proteins to encapsidate and replicate its RNA genome. M1 can replicate and be maintained in the cell without L-A virus if the viral proteins are provided from a vector. We isolated M1 virions from L-A virus-free cells to avoid the preparation from being contaminated with L-A virus. M1 virions purified through a CsCl gradient synthesized full-length M1 transcripts in the presence of four NTPs and produced a short 17 nt transcript when CTP was omitted (Fig. 5B) . The 17 nt transcript labeled with [α-
32 P]GTP was purified through an acrylamide gel, treated with S1 nuclease, and analyzed by PEI cellulose chromatography. As shown in Fig. 5C , lane 2, the transcript produced two spots corresponding to GDP and GMP and their ratio was 1:2.1. In addition to the 5' terminal G, the 17 nt transcript has two additional Gs (Fig. 5A ) and these internal Gs are expected to be released as GMP upon S1 digestion. The results, therefore, suggest that GDP was derived from the 5' end of the transcript and that the transcript thus has diphosphate at the 5' end. To confirm that GDP was derived from the 5' end, the 17 nt transcript was treated with RNA 5' polyphosphatase, ethanol precipitated and then digested with S1 nuclease. As shown in Fig. 5C , lane 3, now, the transcript only produced GMP, indicating that GDP was really released from the 5' end.
5' Diphosphorylated L-A Transcript is Resistant to Ski1p 5' Exonuclease-L-A transcript
has a diphosphate at the 5' end. We wondered whether the viral transcript is susceptible to Ski1p 5' exonuclease. A. Stevens purified this enzyme and performed an extensive biochemical analysis on it. It is now well known that the nuclease digests 5' monophosphorylated RNA as substrate but works poorly on 5' triphosphorylated or capped RNA (37) . However, we did not find information on its reactivity toward 5' diphosphorylated RNA. We, therefore, purified Ski1p as a TAP fusion protein from yeast cells by one-step purification using calmodulin-affinity resin following the method described in (31) . Fig.  6A shows the elution profile of Ski1p from the affinity resin visualized by silver staining. RNA substrates with different 5' termini but having the same nucleotide sequence were made in vitro using T7 RNA polymerase and served to test the specificity of the purified enzyme. As shown in (Fig. 1C) . From these results we concluded that L-A viral transcript made in vitro is a poor substrate for the Ski1p 5' exonuclease.
DISCUSSION
In this work we have demonstrated that L-A transcripts made in vitro by L-A virions are 5' diphosphorylated. More significantly, irrespective of whether transcription was primed by GTP or GMP, the guanine nucleotide incorporated at the 5' terminus was diphosphorylated. Thus the virus deliberately synthesizes RNA transcript with 5' diphosphate. M1, a satellite RNA of L-A virus, utilizes Gag and Gag-Pol of the helper virus to encapsidate and replicate its RNA genome. Isolated M1 virions likewise synthesized transcripts with 5' diphosphate. We have also demonstrated that the L-A transcript made in vitro is a poor substrate for the Ski1p 5' exonuclease. When the 5' end of the transcript was converted from diphosphate to monophosphate, however, Ski1p efficiently digested it. Previously we observed that the deletion of SKI1 resulted in a 5-to 10-fold increase in the copy number of L-A virus and that overexpression of Ski1p cured L-A virus from the cell at a high frequency (22) . Because Ski1p is the major exonuclease involved in mRNA degradation in the budding yeast (19) , our results suggest that the virus makes its transcript 5' diphosphorylated apparently to protect it from a direct attack of the potent Ski1p. Our results also suggest that the host cell possesses an RNA diphosphatase activity in the cytoplasm to convert the viral transcript from diphosphate to monophosphate at the 5' end. Consistent with this view is that in ski1Δ strains L-A transcripts accumulate in large amounts and can easily be detected by Northern hybridization. Furthermore these transcripts are 5' monophosphorylated, as judged from their susceptibility to Terminator 5' exonuclease or purified Ski1p 2 . In wild type strains these transcripts are quickly digested by Ski1p and do not accumulate in large quantities. These observations suggest that in a hypothetical RNA diphosphatase-negative strain viral transcripts will be stabilized because of the inability of Ski1p to directly attack them. Thus these mutants are expected to exhibit a "superkiller" phenotype when harboring the satellite M1 dsRNA.
Another possible role for the 5' diphosphate status of the viral transcript is on translation and is more speculative. Here we demonstrated that the cap analogue m 7 GpppG can be used to prime transcription in vitro by L-A virions. Barbone et al. (38) reported that viral transcripts made in vitro in the presence of the cap analogue are translated in a yeast cell-free translation system 8-to 15-fold more efficiently than the ones made in its absence, although they failed to directly prove its incorporation into viral transcripts. These data together suggest that viral transcripts with 5' diphosphate are poor templates for translation but that the incorporation of the cap structure at the 5' end converted them to more efficient templates. In the mRNA capping reaction, the RNA guanylyltransferase (GTase) transfers GMP to the diphosphate end of pre-mRNA through a covalent enzyme-GMP intermediate. It has been known that L-A Gag protein binds to 5' capped mRNAs and forms a covalent bond with m 7 GMP through His-154 while releasing the mRNA body (25, 39) . This raises the possibility that the m 7 GMP attached to His-154 can be transferred to the diphosphate end of an emerging viral transcript, thus forming a 5' cap structure on the RNA. A 5' capped species of viral RNA has not been detected yet (40) presumably because the efficiency of transfer is low. This cap-snatching hypothesis was originally described in (25) . In the conventional capping reaction, the GTase forms a covalent bond with GMP through Lys but not His. However, it has recently been demonstrated that in the capping reaction of vesicular stomatitis virus (VSV), L protein forms an intermediate by covalently binding the 5' monophosphorylated premRNA through His and transfers the bound premRNA to GDP (41). It appears that members of the Alphavirus-like superfamily also utilize His to form a phosphoamide bond with m 7 GMP and transfer the m 7 GMP moiety to the 5' diphosphate end of a viral transcript during the capping reaction (42 -44). L-A Gag with mutations at His-154 failed to form a covalent bond with m 7 GMP but did not affect replication and maintenance of M1 (25) . Therefore, those reactions, including transcription ((+) strand RNA synthesis), encapsidation of (+) strand into the virion and (-) strand synthesis inside the virion, are not affected by the mutations. Furthermore, M1 virions with a mutant Gag (Arg-154) synthesize M1 transcripts with 5' diphosphate as wild type virions do 2 . Interestingly, however, the expression of M1-encoded killer toxin is severely compromised in vivo by the mutations at His-154 (25), suggesting a specific role of His-154 on translation. Therefore, these data fit well within the framework of this capping hypothesis.
We observed a weak nucleoside triphosphatase activity associated with L-A virions. However, it is not clear whether this activity is involved in the synthesis of the 5' diphosphorylated transcript primed with GTP. RNA polymerase may preferentially incorporate GDP generated by nucleoside triphosphatase over GTP to prime transcription. The polymerase itself may be able to convert GTP to GDP during transcription initiation. Finally, the conversion may occur post-transcriptionally on the nascent transcript during its release from the virion through a pore in the capsid. Our data indicate that the host CTL1 RNA triphosphatase is not involved in this process. The conversion from triphosphate to diphosphate, however, is not essential for the initiation of transcription because a cap analogue (m 7 GpppG) or γ-S-GTP could prime transcription efficiently. GDP was a better substrate to prime transcription than GTP. This raises the possibility that the conversion of GTP to GDP is slow and this slow process might be responsible for the low efficiency of the GTP-primed reaction. However, because γ-S-GTP could prime transcription as efficiently as GTP, this possibility is unlikely. We demonstrated that GMP-primed transcript had also diphosphate at the 5' end, the β-phosphate of which was derived from the γ-phosphate of ATP. This kinase reaction could occur before, during or after transcription initiation, as discussed above for the conversion from triphosphate to diphosphate. It is noteworthy to mention that, when M1 transcription was primed by GMP in the presence of ATP and UTP, we observed not the 10 nt transcript but a longer 17 nt species that had incorporated two internal Gs before termination due to the lack of CTP 2 . This suggests that the virion sequentially converted GMP to GDP and then to GTP at the expense of ATP, and used this newly made GTP to synthesize the 17 nt species. It is thus conceivable that the GDP produced in this process was incorporated at the 5' end of the viral RNA during transcription initiation. Leibowitz's lab (36) has observed that L-A virions are associated with numerous nucleotide-metabolizing enzyme activities, including nucleoside triphosphate phosphotransferase, nucleoside diphosphate and monophosphate kinases, in addition to inorganic pyrophosphatase activity, and speculated that these enzymes may allow the virus to utilize nucleotide pools distinct from those used in host cell transcription. However, the results shown in this work raise the possibility that some of the enzymatic activities associated with the virion are directly involved in the metabolism of phosphate group at the 5' termini of viral transcripts. L-A virus encodes only two proteins, Gag and Gag-Pol. Gag has decapping activity of mRNA and the Pol domain of the fusion protein has RNA-dependent RNA polymerase motifs and is also involved in packaging of viral RNA into virions (45). It is an open question whether the viral proteins further possess these phosphatemetabolizing enzymatic activities. Alternatively, the virus may recruit host enzymes and specifically incorporate them into the virion to process the 5' ends during transcription.
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Masison, D. C., Blanc, A., Ribas, J. C., Carroll, K., Sonenberg, N. 32 P]GTP. Upon S1 nuclease digestion the two internal Gs in the transcript will be released as GMP, while the 5' terminal G would be GDP if the transcript has diphosphate at the 5' end. C.
LEGENDS TO FIGURES
[α-
32 P]GTP-labeled M1 17 nt transcript was isolated from an acrylamide gel and treated with S1 nuclease. The digest was analyzed on PEI cellulose with 1 M LiCl (lane 2). The ratio of radioactive label in GDP and GMP quantified by phosphoimager was 1:2.1. Lane 1 indicates non-S1 digested sample. In lane 3, the 17 nt transcript was first treated with RNA 5' polyphosphatase to eliminate the β phosphate at the 5' end. After ethanol precipitation, then, the transcript was digested with S1 nuclease. Figure 6 . L-A transcript made in vitro is resistant to Ski1p. A. Purification of Ski1p. Ski1p-TAP was purified through a calmodulin affinity resin column. The bound protein was eluted stepwise with a buffer containing EGTA. Protein was separated with SDS-PAGE and visualized by silver staining. Lane 1, the last wash of the column. Lanes 2 to 7, fractions eluted with EGTA. M, molecular standards (kDa). B. Specificity of purified Ski1p. Transcripts bearing 5' pppG-, 5' pG-or 5' cap-structure were made in vitro by T7 RNA polymerase using the same DNA template as described in Experimental Procedures. The transcripts were incubated with Ski1p and the digest was separated in an agarose gel and visualized by ethidium bromide staining. C.
32 P-labeled 16 nt transcript was made in vitro by L-A virions in a CTPomitted transcription reaction and treated with RNA 5' polyphosphatase (RPPase) and/or purified Ski1p as indicated below the panel. Then the transcript was separated in a acrylamide gel and visualized by autoradiography.
